02/12/2026
Cannabis-Induced Psychosis: What Clinicians (and the Public) Need to Know
As clinicians and mental health professionals, we must look at evolving science — especially when it affects youth and vulnerable populations.
In my presentation ("Cannabis-Induced Psychosis: What Clinicians Need to Know"), I break down what the research tells us about how high-potency cannabis can trigger psychotic symptoms.
Particularly in teens and young adults, and what we can do to recognize and respond to these cases in clinical settings.
Watch the full talk here: https://youtu.be/q032n73kDtc
This conversation has never been more critical.
A recent New York Times editorial — reflecting on more than a decade of cannabis policy — acknowledges that widespread legalization without sufficient regulation has led to a surge in daily use and associated health concerns, including rises in addiction and mental health problems.
While The Times stopped short of calling for a return to prohibition, it emphasized the need for stronger regulation, better public education, monitoring of high-THC products, and more clinician awareness — points that align with what we’re seeing in practice.
Key Takeaways for Clinicians & Caregivers
• Cannabis-induced psychosis is a real and clinically significant condition — most often emerging in those with underlying vulnerabilities.
• Daily or high-THC use increases risk — especially among adolescents and young adults.
• Early recognition, supportive care, and evidence-based intervention make a difference in outcomes.
As the national conversation shifts, clinicians, families, educators, and policymakers all have a role in balancing individual freedoms with public health and safety.
Let’s keep advancing evidence-based understanding so we can support patients with clarity, compassion, and care.